Shares of HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report) were down 1.5% on Monday . The company traded as low as $2.91 and last traded at $2.91. Approximately 100 shares changed hands during trading, a decline of 87% from the average daily volume of 762 shares. The stock had previously closed at $2.95.
HLS Therapeutics Trading Down 1.5 %
The stock has a fifty day simple moving average of $2.76 and a two-hundred day simple moving average of $2.59.
About HLS Therapeutics
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
Featured Articles
- Five stocks we like better than HLS Therapeutics
- 3 Fintech Stocks With Good 2021 Prospects
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Conference Calls and Individual Investors
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- The How And Why of Investing in Oil Stocks
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
